Innovations and Challenges in Prostate Cancer
Sixth Cambridge Conference
October 2006
Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference
P. W. Kantoff, T. M. Beer, A. V. D’Amico, R. S. Dipaola, M. A. Eisenberger, M. Hussain, W. K. Kelly, P. Mathew, C. J. Ryan, H. M. Sandler, I. M. Thompson, P. R. Carroll
Chemoprevention of Prostate Cancer: Agents and Study Designs
I. M. Thompson, MD
Contemporary Trends in Low-Risk Prostate Cancer: Risk Assessment and Treatment
M. R. Cooperberg, J. M. Broering, A. Bakst, P. W. Kantoff, P. R. Carroll
Assessing and Treating Patients With Increasing Prostate Specific Antigen Following Radical Prostatectomy
H. M. Sandler and M. A. Eisenberger
Prostate Specific Antigen Only Androgen Independent Prostate Cancer: Natural History, Challenges in Management, and Clinical Trial Design
C. J. Ryan and T. M. Beer
Castration Resistant Taxane Naïve Metastatic Prostate Cancer: Current Clinical Approaches and Future Directions
G. A. Gignac, M.J. Morris, M. Hussain
Taxane Refractory Prostate Cancer
P. Mathew and R. DiPaola
Bone Directed Therapies for Prostate Cancer
D. A. Bradley, M. Hussain, R. S. DiPaola, P. Kantoff
